I hope to see holders tune in and ask the important questions.I personally will ask the below if given the opportunity:1) Why is revenue uptick been sluggish for a proven product, with the company having soo many regulatory approvals and market education going on; What is the real barrier here ? Is it cost ? or something more pressing ?2) Is there an update on CR ? The company is playing it too close to the chest with liquidity - this is clearly hurting SP - is there a plan for an institutional placement ?3) Understand the focus on China - however, India is another high populous nation - why are we not seeing revenue uptick over there ? It's not even 10 - 20K in revenue out of India - why is that ?
Ann: Investor Webinar Presentation, page-5
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.0¢ |
Change
-0.001(1.96%) |
Mkt cap ! $5.746M | |||
| Open | High | Low | Value | Volume |
| 5.2¢ | 5.3¢ | 5.0¢ | $65.68K | 1.294M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 182898 | 5.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 841172 | 6 |
View Market Depth
| Last trade - 16.10pm 30/07/2024 (20 minute delay) ? |
| OSX (ASX) Chart |